Check the Batch
Class IITerminated in FDA datasetRecall initiated Oct 24, 2013

Dual Action Cleanse by Cellular Research Formulas, 60 ct, Item AN027370

Recalling firm: Irwin Naturals

Why it was recalled

Irwin Naturals is recalling Daily Digestive Enzymes and Dual Action Cleanse because they may possibly be contaminated with chloramphenicol.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Jul 2, 2014.

Check your package

Compare the exact product and package details with the label you have.

ProductDual Action Cleanse by Cellular Research Formulas, 60 ct, Item AN027370, UPC 7 10363 27370 5, Item AN056592HFS, UPC 7 10363 56592 3; Item DR056439, UPC 7 10363 57369 0.
UPC710363273705, 710363565923, 710363573690

FDA code information

Lot # T3F006

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Dual Action Cleanse by Cellular Research Formulas, 60 ct, Item AN027370, UPC 7 10363 27370 5, Item AN056592HFS, UPC 7 10363 56592 3; Item DR056439, UPC 7 10363 57369 0.

Extracted codes and context

TypeCode / valueContext
UPC710363273705Dual Action Cleanse by Cellular Research Formulas, 60 ct, Item AN027370, UPC 7 10363 27370 5, Item AN056592HFS, UPC 7 10363 56592 3; Item DR056439, UPC 7 10363 57369 0.
UPC710363565923arch Formulas, 60 ct, Item AN027370, UPC 7 10363 27370 5, Item AN056592HFS, UPC 7 10363 56592 3; Item DR056439, UPC 7 10363 57369 0.
UPC710363573690 UPC 7 10363 27370 5, Item AN056592HFS, UPC 7 10363 56592 3; Item DR056439, UPC 7 10363 57369 0.
lotT3F006Lot # T3F006

Original FDA recall reason

Irwin Naturals is recalling Daily Digestive Enzymes and Dual Action Cleanse because they may possibly be contaminated with chloramphenicol.

Recall details

Recall number
F-0118-2014
Event ID
66602
FDA status
Terminated
Initiated
Oct 24, 2013
Reported
Nov 13, 2013
Classified
Nov 7, 2013
Terminated
Jul 2, 2014
Quantity
1271 units
Location
Los Angeles, CA, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

Nationwide in US

FDA source record · F-0118-2014

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.